LyondellBasell enters into an agreement and exclusive negotiations with AEQUITA for the sale of four European Strategic Assessment assets 5-06-2025, 16:00

Junshi Biosciences Announces Toripalimab plus Chemotherapy Significantly Improved Event-free Survival (EFS) versus Chemotherapy as Perioperative Treatment for Resectable Stage III Non-small Cell Lung Cancer (NSCLC) in Phase 3 Neotorch Study 21-04-2023, 03:01

Libro Credit Union Selects nCino to Empower Employees and Positively Impact Ontario Community 30-04-2024, 18:30